Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filomena de Nigris

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
International Journal of Molecular Sciences|April 28, 2023
Basic Pathogenic Mechanisms and Epigenetic Players Promoted by Extracellular Vesicles in Vascular DamageConcetta Schiano, Carolina Balbi, Filomena de Nigris, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|June 3, 2025
Raf kinase inhibitor protein modulator of gut microbiota and immunotherapy responses in cancerGiuseppe Palma, Francesca Bruzzese, Concetta Meo, et al.
Recent Patents on Anti-Cancer Drug Discovery|March 2, 2012
CXCR4 inhibitors: tumor vasculature and therapeutic challengesFilomena de Nigris, Concetta Schiano, Teresa Infante, et al.
Expert Review of Clinical Immunology|December 21, 2018
New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesionsConcetta Schiano, Andrea Soricelli, Filomena De Nigris, et al.
Current Opinion in Cardiology|February 19, 2021
Emergent expansion of clinical epigenetics in patients with cardiovascular diseasesClaudio Napoli, Enrico Coscioni, Filomena de Nigris, et al.
Frontiers in Endocrinology|January 1, 2021
Clinical Epigenetics of Neuroendocrine Tumors: The Road AheadAnnamaria Colao, Filomena de Nigris, Roberta Modica, et al.
Neoplasia (New York, N.Y.)|May 4, 2002
c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?Claudio Napoli, Lilach O Lerman, Filomena de Nigris, et al.
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Epigenetic Dysregulation in Advanced Kidney Cancer: Opportunities for Therapeutic InterventionsAustin Goldsamt, Nur P Damayanti, Filomena De Nigris, et al.
Journal of Translational Medicine|April 21, 2023
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatmentConcetta Meo, Giuseppe Palma, Francesca Bruzzese, et al.
Journal of the American College of Cardiology|October 24, 2002
Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cellsClaudio Napoli, Lilach O Lerman, Filomena de Nigris, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
International Journal of Molecular Sciences|April 28, 2023
Basic Pathogenic Mechanisms and Epigenetic Players Promoted by Extracellular Vesicles in Vascular DamageConcetta Schiano, Carolina Balbi, Filomena de Nigris, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|June 3, 2025
Raf kinase inhibitor protein modulator of gut microbiota and immunotherapy responses in cancerGiuseppe Palma, Francesca Bruzzese, Concetta Meo, et al.
Recent Patents on Anti-Cancer Drug Discovery|March 2, 2012
CXCR4 inhibitors: tumor vasculature and therapeutic challengesFilomena de Nigris, Concetta Schiano, Teresa Infante, et al.
Expert Review of Clinical Immunology|December 21, 2018
New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesionsConcetta Schiano, Andrea Soricelli, Filomena De Nigris, et al.
Current Opinion in Cardiology|February 19, 2021
Emergent expansion of clinical epigenetics in patients with cardiovascular diseasesClaudio Napoli, Enrico Coscioni, Filomena de Nigris, et al.
Frontiers in Endocrinology|January 1, 2021
Clinical Epigenetics of Neuroendocrine Tumors: The Road AheadAnnamaria Colao, Filomena de Nigris, Roberta Modica, et al.
Neoplasia (New York, N.Y.)|May 4, 2002
c-Myc oncoprotein: a dual pathogenic role in neoplasia and cardiovascular diseases?Claudio Napoli, Lilach O Lerman, Filomena de Nigris, et al.
Cancer Journal (Sudbury, Mass.)|September 18, 2020
Epigenetic Dysregulation in Advanced Kidney Cancer: Opportunities for Therapeutic InterventionsAustin Goldsamt, Nur P Damayanti, Filomena De Nigris, et al.
Journal of Translational Medicine|April 21, 2023
Spontaneous cancer remission after COVID-19: insights from the pandemic and their relevance for cancer treatmentConcetta Meo, Giuseppe Palma, Francesca Bruzzese, et al.
Journal of the American College of Cardiology|October 24, 2002
Glycoxidized low-density lipoprotein downregulates endothelial nitricoxide synthase in human coronary cellsClaudio Napoli, Lilach O Lerman, Filomena de Nigris, et al.
Pageof 9